SDAC

San Diego Angel Conference VI Announces Six Finalists to Compete for Share of Largest Event-Based Angel Fund in U.S.

Retrieved on: 
Monday, March 25, 2024
Professional Services, Consumer, Small Business, Entrepreneur, Start-Up, Finance, Organization, Conference, SDAC, SDSU, UCSD, Brink, JPMorgan Chase, University, Pillsbury Winthrop Shaw Pittman, University of California, Gust, San Diego State University, Financial services

The San Diego Angel Conference at USD has become the largest event-based angel conference in the country , with an active angel investor group of about 90 accredited investors who invest starting at $7,000 each.

Key Points: 
  • The San Diego Angel Conference at USD has become the largest event-based angel conference in the country , with an active angel investor group of about 90 accredited investors who invest starting at $7,000 each.
  • “The San Diego Angel Conference is truly a unique opportunity for both investors and founders to experience the hands-on learning opportunities of the investment decision process,” Executive Director, JPMorgan Startup Banking David Loseke.
  • SDAC partners with 35+ organizations including USD , San Diego State University ( SDSU ), and University of California, San Diego ( UCSD ), to drive deal flow and mentor startups.
  • SDAC Founder Mysty Rusk says, “Over six years, San Diego Angel Conference at USD has focused on activating accredited investors, funding innovative early-stage companies, and supporting solutions that solve real-world problems.

San Diego Angel Conference VI at University of San Diego Announces Quarterfinalists

Retrieved on: 
Friday, February 23, 2024
Professional Services, Consumer, Small Business, Entrepreneur, Start-Up, Finance, Gust, Mentorship, Pillsbury Winthrop Shaw Pittman, Leg, San Diego State University, Conference, University, SDAC, SDSU, Organization, University of California, Brink, JPMorgan Chase, UCSD

They took home $269,000 in funding at the SDAC V conference and secured additional funds from investors and from UCSD within weeks of the event.

Key Points: 
  • They took home $269,000 in funding at the SDAC V conference and secured additional funds from investors and from UCSD within weeks of the event.
  • LIMBER CEO Dr. Joshua Pelz says, “The seed funding we received through SDAC enabled us to invest in product development and accelerate commercialization.
  • The San Diego Angel Conference at USD has become the largest event-based angel conference in the country .
  • SDAC partners with 35+ organizations including USD , San Diego State University ( SDSU ), and University of California, San Diego ( UCSD ), to drive deal flow and mentor startups.

San Diego Angel Conference at USD Opens 2024 SDAC VI Fund to Angel Investors as Applications for Founders Seeking Funding Close on December 19

Retrieved on: 
Friday, December 8, 2023
Finance, Consulting, Professional Services, Small Business, Start-Up, Other Education, University, Other Professional Services, Education, SDSU, Organization, University of San Diego, Investment, Learning, Social capital, USD, First Republic Bank, Brink, Conference, University of California, San Diego State University, Environment, MSF, UCSD, Financial services, Cryptocurrency, SDAC

San Diego Angel Conference at the University of San Diego (SDAC) activates angel investors and connects them with early-stage companies seeking seed funding.

Key Points: 
  • San Diego Angel Conference at the University of San Diego (SDAC) activates angel investors and connects them with early-stage companies seeking seed funding.
  • SDAC angel investors can expand their network through structured seminars, and socials, and by becoming a member of the USD President’s Club.
  • SDAC partners with 35+ organizations including University of San Diego ( USD ), San Diego State University ( SDSU ), and University of California, San Diego ( UCSD ), to drive deal flow and mentor startups.
  • SDAC Founder Mysty Rusk says, “We activate angel investors and fund companies with potential to solve some of the world’s biggest problems.

CARI Health Awarded NIH Grant of up to $2.8M to Advance Remote Medication Monitoring

Retrieved on: 
Thursday, October 19, 2023
Wearables, Mobile Technology, Technology, Medical Devices, Health Technology, Biometrics, Biotechnology, Managed Care, General Health, Pharmaceutical, Health, Digital, Research, Opioid use disorder, Marianne Schmidl, SDAC, Global Entrepreneur, UCSD, Medtech, Conference, Methadone, CARI, National Institute on Drug Abuse, NIDA, University, Device, NIH, Investment, Patient, Bangladesh Technical Education Board, Pharmaceutical industry

Digital health startup CARI Health was awarded an SBIR Fast Track grant from the National Institute on Drug Abuse (NIDA), an agency of the National Institutes of Health (NIH), to help it bring the world’s first wearable medication monitor to market.

Key Points: 
  • Digital health startup CARI Health was awarded an SBIR Fast Track grant from the National Institute on Drug Abuse (NIDA), an agency of the National Institutes of Health (NIH), to help it bring the world’s first wearable medication monitor to market.
  • CARI Health is eligible for up to $2.8M over three years as project milestones are successfully completed within Phase I and Phase II portions of the grant.
  • The award funding will go toward supporting product development and conducting human clinical studies for CARI Health’s wearable remote medication monitoring device .
  • The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.

San Diego Angel Conference at USD’s Knauss School of Business Launches SDAC VI Fund with Two Major Events: Entrepreneur Program Kick Off/Mixer and Alternative Funding Expo

Retrieved on: 
Monday, September 11, 2023
Consulting, University, Start-Up, Education, Professional Services, Business, Small Business, Other Professional Services, Crowdfunding, Other Education, Finance, SDAC, SDEE, Partnership, Brink, USD, Investment, University of San Diego, Conference, Cryptocurrency, Financial services

San Diego Angel Conference (SDAC), a program within University of San Diego (USD) Knauss School of Business and in partnership with The Brink SBDC , is launching its sixth angel conference series – SDAC VI – to activate accredited angel investors and mentor promising early-stage companies.

Key Points: 
  • San Diego Angel Conference (SDAC), a program within University of San Diego (USD) Knauss School of Business and in partnership with The Brink SBDC , is launching its sixth angel conference series – SDAC VI – to activate accredited angel investors and mentor promising early-stage companies.
  • SDAC provides guidance, education, resources, and valuable connections to early-stage companies seeking angel funding, while actively engaging first-time and experienced angel investors.
  • The San Diego Entrepreneurs Exchange (SDEE), a valued SDAC partner, is also sponsoring the mixer for the kick off of SDAC’s Entrepreneurs Track (E-Track), on Sept. 12.
  • The E-Track is open to early-stage company founders to develop, explore, and refine fundamentals required to seek angel investment.

BioCardia Announces Interim Efficacy Results in Phase III Pivotal CardiAMP Cell Therapy Heart Failure Trial

Retrieved on: 
Tuesday, September 5, 2023
Knowledge, Moyamoya disease, SDAC, Madison, University, Therapy, Heart failure, Myocardial infarction, BCDA, DSMB, Hospital, Principal investigator, Bell P-76, Stroke, Survival, HF, MACC, University of Wisconsin–Madison, Cell, GDMT, Patient, Heart, FS, FDA, Death, Safety, Jan Vansina, Pharmaceutical industry, Dietary supplement, MD, Medicine

SUNNYVALE, Calif., Sept. 05, 2023 (GLOBE NEWSWIRE) -- BioCardia®, Inc. [Nasdaq: BCDA], a developer of cellular and cell-derived therapeutics for the treatment of cardiovascular and pulmonary disease, today announced it has finalized external review of interim data and evaluated interim efficacy results for the ongoing Phase III pivotal trial of CardiAMP ® Cell Therapy for Heart Failure (CardiAMP HF, clinicaltrials.gov Identifier: NCT02438306), for which the FDA granted Breakthrough Designation for the treatment of heart failure of reduced ejection fraction (HFrEF).

Key Points: 
  • SUNNYVALE, Calif., Sept. 05, 2023 (GLOBE NEWSWIRE) -- BioCardia®, Inc. [Nasdaq: BCDA], a developer of cellular and cell-derived therapeutics for the treatment of cardiovascular and pulmonary disease, today announced it has finalized external review of interim data and evaluated interim efficacy results for the ongoing Phase III pivotal trial of CardiAMP ® Cell Therapy for Heart Failure (CardiAMP HF, clinicaltrials.gov Identifier: NCT02438306), for which the FDA granted Breakthrough Designation for the treatment of heart failure of reduced ejection fraction (HFrEF).
  • This review was based on the three-tiered Finkelstein-Schoenfeld (FS) hierarchical analysis of 12-month data, whose composite score comprises the primary efficacy endpoint of the CardiAMP HF study.
  • These limited interim results related to the primary efficacy endpoint have been shared with the Co-National Principal Investigators of the study.
  • Knowledge from these interim details may be incorporated in its ongoing development plans for its autologous CardiAMP and allogeneic CardiALLO cell therapy programs.

Sustainable Development Acquisition I Corp. Announces Liquidation

Retrieved on: 
Thursday, July 13, 2023
Banking, Professional Services, Finance, Transfer, SDAC, Common stock, IPO, Tax, Trust, Bangladesh Securities and Exchange Commission, Accounting, Development, Interest on Lawyer Trust Accounts, CST, Finance Secretary (India), Trustee, Security (finance)

In order to provide for the disbursement of funds from the Trust Account, the Company has instructed the Trustee of the Trust Account to take all necessary actions to liquidate the Trust Account.

Key Points: 
  • In order to provide for the disbursement of funds from the Trust Account, the Company has instructed the Trustee of the Trust Account to take all necessary actions to liquidate the Trust Account.
  • The proceeds of the Trust Account will be held in a non-interest bearing account while awaiting disbursement to the holders of the Public Shares.
  • Investors holding through a broker need to take no action in order to receive payment.
  • The redemption of the Public Shares is expected to be completed on or about July 24, 2023 (the “Redemption Date”).

LIMBER Prosthetics & Orthotics Awarded $200,000+ in Funding at San Diego Angel Conference V with Relavo Winning at Least $150,000 and Athletiverse Receiving at Least a $75,000 Investment

Retrieved on: 
Monday, April 24, 2023
Professional Services, Education, Health, Medical Devices, Start-Up, Continuing, University, University of San Diego, SDAC, Business, Mentorship, Conference, USD, Financial services

San Diego Angel Conference (SDAC), a University of San Diego (USD) Knauss School of Business program now in its fifth year that activates accredited angel investors and engages promising early-stage companies, today awarded three startups with angel funding for their potentially disruptive solutions.

Key Points: 
  • San Diego Angel Conference (SDAC), a University of San Diego (USD) Knauss School of Business program now in its fifth year that activates accredited angel investors and engages promising early-stage companies, today awarded three startups with angel funding for their potentially disruptive solutions.
  • LIMBER Prosthetics & Orthotics took the top prize with $200,000* in funding for its affordable, personalized prosthetics.
  • Runners up were awarded funding as follows:
    *Actual amount raised by the finalists could increase as investors may elect to invest in the startups as individual investors.
  • Accredited angel investors nationwide invested anywhere from $7,000 to $40,000 to form a collective SDAC V fund.

San Diego Angel Conference V, Sponsored by C3bank, Announces Six Finalists to Compete for Share of Record-Breaking Fund

Retrieved on: 
Monday, March 20, 2023
Other Professional Services, Finance, Start-Up, Banking, Small Business, Professional Services, University, Education, SDAC, Organization, Ecosystem, Quality of life, First Republic Bank, UCSD, Mentorship, SDSU, USD, Cryptocurrency, Financial services

“SDAC V angel investors selected finalists that show potential of a strong return and offer a unique solution that can improve the quality of life for millions.

Key Points: 
  • “SDAC V angel investors selected finalists that show potential of a strong return and offer a unique solution that can improve the quality of life for millions.
  • With seed funding and the mentoring provided by SDAC, these founders will undoubtedly impact their industries and communities,” says C3bank CEO Adam J.
  • These connections, combined with SDAC’s reputation for excellence, enables it to attract promising startups and manage a substantial investment fund.
  • SDAC Founder Mysty Rusk says, “SDAC is focused on activating accredited investors, funding innovative early-stage companies, and supporting solutions that solve real-world problems.

San Diego Angel Conference V Announces 13 Startup Semifinalists as Angel Fund Surpasses Estimates

Retrieved on: 
Friday, March 10, 2023
Finance, Start-Up, Professional Services, Other Professional Services, Small Business, Organization, Ecosystem, SDSU, Mintz, Conference, SDAC, Series, USD, UCSD, First Republic Bank, Financial services

We are now in our Series A and grateful to SDAC for the coaching, connections and ongoing support.

Key Points: 
  • We are now in our Series A and grateful to SDAC for the coaching, connections and ongoing support.
  • We congratulate the SDAC V semifinalists and wish them luck moving forward,” says Baburek.
  • With an active angel investor group of about 90 accredited investors, who invest anywhere from $7,000 to $100,000+ each conference series, the San Diego Angel Conference has become one of the largest event-based angel funds in the country .
  • SDAC V investors are responding to that and we are already well above our goal for the angel fund.